"Visit the UCLA Health website for coronavirus updates."

During the past decade, UCLA/Santa Clarita Valley Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCLA/Santa Clarita Valley Cancer Center" #1 sponsor was "Pfizer" with 8 trials, followed by "Chiron Corporation" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "ImmunoGen, Inc." with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA/Santa Clarita Valley Cancer Center" #1 collaborator was "Medivation, Inc." with 4 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UCLA/Santa Clarita Valley Cancer Center" are "Breast Cancer" (2 trials), "Advanced Solid Tumors" (1 trials), "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "UCLA/Santa Clarita Valley Cancer Center" in a lesser frequency.

Most popular intervention types in "UCLA/Santa Clarita Valley Cancer Center" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Talazoparib" (3 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA/Santa Clarita Valley Cancer Center" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA/Santa Clarita Valley Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in UCLA/Santa Clarita Valley Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA/Santa Clarita Valley Cancer Center, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".